ES2187597T3 - Derivados de la piperidinilmetiloxazolidin-2-ona, su obtencion y su empleo como compuestos eficaces para el sistema nervioso central. - Google Patents

Derivados de la piperidinilmetiloxazolidin-2-ona, su obtencion y su empleo como compuestos eficaces para el sistema nervioso central.

Info

Publication number
ES2187597T3
ES2187597T3 ES96112990T ES96112990T ES2187597T3 ES 2187597 T3 ES2187597 T3 ES 2187597T3 ES 96112990 T ES96112990 T ES 96112990T ES 96112990 T ES96112990 T ES 96112990T ES 2187597 T3 ES2187597 T3 ES 2187597T3
Authority
ES
Spain
Prior art keywords
sub
sup
atoms
rent
ona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96112990T
Other languages
English (en)
Inventor
Helmut Prucher
Gerd Bartoszyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2187597T3 publication Critical patent/ES2187597T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA INVENCION TRATA DE NUEVOS DERIVADOS DE LA PIPERIDINIL-METILOXAZOLIDIN-2-ONA DE FORMULA I EN DONDE R{SUP,1} Y R{SUP,2} SON, CADA UNO INDEPENDIENTEMENTE DEL OTRO, RESTOS FENILICOS INSUSTITUIDOS O MONO- O BI-SUSTITUIDOS, CUYOS SUSTITUYENTES PUEDEN SER A, OA, ARILOXI CON 6-10 ATOMOS DE C, ARALQUILOXI CON 7-11 ATOMOS DE C, -O-(CH{SUB,2}){SUB,N}-O(UNIDOS AL ANILLO DE FENILO EN POSICIONES CONTIGUAS O EN POSICION META O PARA UNO CON RESPECTO AL OTRO), -O-(CH{SUB,2}){SUB,N}-OH, HALOGENO, CF{SUB,3}, OH, NO{SUB,2}, NH{SUB,2}, NHA, NA{SUB,2}, NHR{SUP,3}, NAR{SUP,3}, SO{SUB,2}NH{SUB,2}, SO{SUB,2}NHA, SO{SUB,2}NA{SUB,2}, SO{SUB,2}NHR{SUP,3} (EXCEPTO R{SUP,3} = SO{SUB,2}A), SO{SUB,2}N(R{SUP,3}){SUB,2} (EXCEPTO R{SUP,3} = SO{SUB,2}A) O R{SUP,3}; R{SUP,3} ES COH, CO-ALQUILO CON 1-7 ATOMOS DE C EN EL ALQUILO, CO-ALQUIL-AR CON 8-12 ATOMOS DE C, CO-AR CON 7-13 ATOMOS DE C, SO{SUB,2}A; A ES UN RADICAL ALQUILICO CON 1-6 ATOMOS DE C; N ES 1 O 2; HALOGENO ES F, CL, BR O I; ASI COMO SUS SALES FISIOLOGICAMENTE ACEPTABLES. LA INVENCION TAMBIEN TRATA DE LA OBTENCION Y UTILIZACION DE ESTOS COMPUESTOS. SE HA HALLADO, QUE LOS COMPUESTOS DE FORMULA I Y SUS SALES FISIOLOGICAMENTE ACEPTABLES POSEEN VALIOSAS PROPIEDADES FARMACOLOGICAS. INFLUYEN EN ESPECIAL EN EL SISTEMA NERVIOSO CENTRAL Y TIENEN EFECTOS SEDANTES, TRANQUILIZANTES, NEUROLEPTICOS Y/O ANTIDEPRESIVOS, SIN HABERSE DEMOSTRADO UN EFECTO CATALEPTICO DIGNO DE CITARSE.
ES96112990T 1995-08-25 1996-08-13 Derivados de la piperidinilmetiloxazolidin-2-ona, su obtencion y su empleo como compuestos eficaces para el sistema nervioso central. Expired - Lifetime ES2187597T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19531321A DE19531321A1 (de) 1995-08-25 1995-08-25 Piperidinylmethyloxazolidinone

Publications (1)

Publication Number Publication Date
ES2187597T3 true ES2187597T3 (es) 2003-06-16

Family

ID=7770390

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96112990T Expired - Lifetime ES2187597T3 (es) 1995-08-25 1996-08-13 Derivados de la piperidinilmetiloxazolidin-2-ona, su obtencion y su empleo como compuestos eficaces para el sistema nervioso central.

Country Status (27)

Country Link
US (1) US5714502A (es)
EP (1) EP0763535B1 (es)
JP (1) JPH09124646A (es)
KR (1) KR970010766A (es)
CN (1) CN1067391C (es)
AR (1) AR004185A1 (es)
AT (1) ATE228517T1 (es)
AU (1) AU715310B2 (es)
BR (1) BR9603509A (es)
CA (1) CA2184052A1 (es)
CO (1) CO4750661A1 (es)
CZ (1) CZ291446B6 (es)
DE (2) DE19531321A1 (es)
DK (1) DK0763535T3 (es)
ES (1) ES2187597T3 (es)
HU (1) HUP9602324A3 (es)
MX (1) MX9603567A (es)
NO (1) NO306993B1 (es)
PL (1) PL185141B1 (es)
PT (1) PT763535E (es)
RU (1) RU2175970C2 (es)
SI (1) SI0763535T1 (es)
SK (1) SK281914B6 (es)
TR (1) TR199600656A2 (es)
TW (1) TW426680B (es)
UA (1) UA43860C2 (es)
ZA (1) ZA967201B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19739332C1 (de) * 1997-09-09 1998-11-26 Merck Patent Gmbh Piperidinylmethyloxazolidinon-Derivat
AU2002223968A1 (en) * 2000-12-21 2002-07-01 Warner Lambert Company Llc Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
WO2005006314A1 (en) * 2003-07-14 2005-01-20 Lg Electronics Inc. Write-once optical disc, method and apparatus for recording management information on write-once optical disc
GB201317609D0 (en) 2013-10-04 2013-11-20 Cancer Rec Tech Ltd Inhibitor compounds
GB201505658D0 (en) 2015-04-01 2015-05-13 Cancer Rec Tech Ltd Inhibitor compounds
GB201617103D0 (en) 2016-10-07 2016-11-23 Cancer Research Technology Limited Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate

Also Published As

Publication number Publication date
AU715310B2 (en) 2000-01-20
UA43860C2 (uk) 2002-01-15
PL185141B1 (pl) 2003-02-28
MX9603567A (es) 1997-06-28
RU2175970C2 (ru) 2001-11-20
PL315801A1 (en) 1997-03-03
AU6215196A (en) 1997-02-27
PT763535E (pt) 2003-04-30
EP0763535A1 (de) 1997-03-19
NO306993B1 (no) 2000-01-24
NO963524D0 (no) 1996-08-23
TR199600656A3 (es) 1997-03-21
NO963524L (no) 1997-02-26
HUP9602324A3 (en) 1998-10-28
TR199600656A2 (tr) 1997-03-21
CZ291446B6 (cs) 2003-03-12
ATE228517T1 (de) 2002-12-15
HUP9602324A2 (hu) 1998-07-28
CA2184052A1 (en) 1997-02-26
CN1148594A (zh) 1997-04-30
DK0763535T3 (da) 2003-03-17
TW426680B (en) 2001-03-21
SK281914B6 (sk) 2001-09-11
JPH09124646A (ja) 1997-05-13
CZ233896A3 (en) 1997-03-12
BR9603509A (pt) 1998-05-12
HU9602324D0 (en) 1996-10-28
US5714502A (en) 1998-02-03
CO4750661A1 (es) 1999-03-31
ZA967201B (en) 1997-03-03
SK106196A3 (en) 1997-04-09
DE59609913D1 (de) 2003-01-09
EP0763535B1 (de) 2002-11-27
KR970010766A (ko) 1997-03-27
AR004185A1 (es) 1998-11-04
SI0763535T1 (en) 2003-08-31
DE19531321A1 (de) 1997-02-27
CN1067391C (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
PE20001551A1 (es) Derivados de eter biarilico como inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc
ES2157593T3 (es) Derivados de la adenosina heterociclicos sustituidos en n6.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2093399T3 (es) Nuevos derivados de acido fosfono-succinico, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
ECSP056097A (es) Antagonistas del receptor cgrp
PE20191784A1 (es) Compuestos inhibidores de vmat2, composiciones y metodos relativos a los mismos
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES2038707T3 (es) Procedimiento para la obtencion de enantiomeros (+) y (-) de derivados de la 3,4-dihidro-2h-(1)-benzopiran-3-amina.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
AR018596A1 (es) Compuestos azapoliciclicos fusionados con arilo utiles en el tratamiento de desordenes neurologicos y fisiologicos, composiciones farmaceuticas,metodos de tratamiento que los utilizan
CR6968A (es) Un nuevo compuesto derivado de la triptamina y sus analogos.
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
PE44199A1 (es) Benzo[e]isoindoles y benzo[h]isoquinolinas triciclicos
ES2163162T3 (es) Procedimiento para el revestimiento de substratos electroconductivos.
PE66798A1 (es) Analogos de la vitamina d3 tratados con fluor
ES2169881T3 (es) Nuevos derivados de amida de pirrolidina sustituidos con heterociclo.
PE20180196A1 (es) Derivados de indol
ES2058269T3 (es) Di-t-butilfenil-alquil y -bencil-eteres.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.